Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 12, 2019 - Issue
Submit an article Journal homepage
222
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia

Thitipon Yaowaluk1 Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
,
Vorapun Senanarong2 Division of Neurology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
,
Chanin Limwongse3 Division of Medical Genetics, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
,
Rasda Boonprasert4 Clinical Toxicology Laboratory, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
&
Pornpimol Kijsanayotin1 Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, ThailandCorrespondence[email protected]
Pages 209-224 | Published online: 04 Sep 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Monpat Chamnanphon, Sorawit Wainipitapong, Teeravut Wiwattarangkul, Phenphichcha Chuchuen, Kunathip Nissaipan, Weeraya Phaisal, Sookjaroen Tangwongchai, Chonlaphat Sukasem, Supeecha Wittayalertpanya, Andrea Gaedigk, Daruj Aniwattanapong & Pajaree Chariyavilaskul. (2020) CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia. Pharmacogenomics and Personalized Medicine 13, pages 543-551.
Read now
Ramon Cacabelos. (2020) Pharmacogenomics of drugs used to treat brain disorders. Expert Review of Precision Medicine and Drug Development 5:3, pages 181-234.
Read now

Articles from other publishers (7)

Federico Emanuele Pozzi, Elisa Conti, Ildebrando Appollonio, Carlo Ferrarese & Lucio Tremolizzo. (2022) Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review. Frontiers in Neuroscience 16.
Crossref
Sara Ben Halla, Amal Tazzite, Bouchaïb Gazzaz, Hind Dehbi & Bouchra El Moutawakil. (2022) The impact of ABCB1 gene polymorphism (C3435T) and its expression on response to Donepezil in Moroccan patients with Alzheimer's disease. Gene Reports 26, pages 101443.
Crossref
Yoshiyuki Kagawa, Yoshiaki Yamamoto, Ayami Ueno, Kengo Inomata, Mayu Tezuka, Takashi Osawa, Yasuharu Yazawa, Toshio Maeda & Tomokazu Obi. (2021) Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders Extra 11:3, pages 264-272.
Crossref
Firoz Akhter, Alicia Persaud, Younis Zaokari, Zhen Zhao & Donghui Zhu. (2021) Vascular Dementia and Underlying Sex Differences. Frontiers in Aging Neuroscience 13.
Crossref
Jin Lu, Xiuzhe Wang, Lili Wan, Jianliang Fu, Yan Huo, Yuwu Zhao & Cheng Guo. (2020) Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy. Frontiers in Pharmacology 11.
Crossref
Derek Spieler, Christian Namendorf, Tamara Namendorf, Maja von Cube & Manfred Uhr. (2020) Donepezil, a cholinesterase inhibitor used in Alzheimer's disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice. Journal of Psychiatric Research 124, pages 29-33.
Crossref
Ramon Cacabelos. (2020) Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia. International Journal of Molecular Sciences 21:9, pages 3059.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.